These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31609590)

  • 1. Drivers of α-Sheet Formation in Transthyretin under Amyloidogenic Conditions.
    Childers MC; Daggett V
    Biochemistry; 2019 Nov; 58(44):4408-4423. PubMed ID: 31609590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edge Strand Dissociation and Conformational Changes in Transthyretin under Amyloidogenic Conditions.
    Childers MC; Daggett V
    Biophys J; 2020 Nov; 119(10):1995-2009. PubMed ID: 33091379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides Composed of Alternating L- and D-Amino Acids Inhibit Amyloidogenesis in Three Distinct Amyloid Systems Independent of Sequence.
    Kellock J; Hopping G; Caughey B; Daggett V
    J Mol Biol; 2016 Jun; 428(11):2317-2328. PubMed ID: 27012425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of α-sheet structure in amyloidogenesis: characterization and implications.
    Prosswimmer T; Daggett V
    Open Biol; 2022 Nov; 12(11):220261. PubMed ID: 36416010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different disease-causing mutations in transthyretin trigger the same conformational conversion.
    Steward RE; Armen RS; Daggett V
    Protein Eng Des Sel; 2008 Mar; 21(3):187-95. PubMed ID: 18276611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomy of an amyloidogenic intermediate: conversion of beta-sheet to alpha-sheet structure in transthyretin at acidic pH.
    Armen RS; Alonso DO; Daggett V
    Structure; 2004 Oct; 12(10):1847-63. PubMed ID: 15458633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is Leu55-->Pro55 transthyretin variant the most amyloidogenic: insights from molecular dynamics simulations of transthyretin monomers.
    Yang M; Lei M; Huo S
    Protein Sci; 2003 Jun; 12(6):1222-31. PubMed ID: 12761393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.
    Armen RS; DeMarco ML; Alonso DO; Daggett V
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11622-7. PubMed ID: 15280548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Atomistic View of Amyloidogenic Self-assembly: Structure and Dynamics of Heterogeneous Conformational States in the Pre-nucleation Phase.
    Matthes D; Gapsys V; Brennecke JT; de Groot BL
    Sci Rep; 2016 Sep; 6():33156. PubMed ID: 27616019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers.
    Hopping G; Kellock J; Barnwal RP; Law P; Bryers J; Varani G; Caughey B; Daggett V
    Elife; 2014 Jul; 3():e01681. PubMed ID: 25027691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial conformational changes of human transthyretin under partially denaturing conditions.
    Yang M; Lei M; Bruschweiler R; Huo S
    Biophys J; 2005 Jul; 89(1):433-43. PubMed ID: 15821170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized structural fluctuations promote amyloidogenic conformations in transthyretin.
    Lim KH; Dyson HJ; Kelly JW; Wright PE
    J Mol Biol; 2013 Mar; 425(6):977-88. PubMed ID: 23318953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insight into E22Q-mutation-induced antiparallel-to-parallel β-sheet transition of Aβ
    Li X; Lei J; Qi R; Xie L; Wei G
    Phys Chem Chem Phys; 2019 Jul; 21(28):15686-15694. PubMed ID: 31271401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of amyloidogenic segments of human transthyretin.
    Saelices L; Sievers SA; Sawaya MR; Eisenberg DS
    Protein Sci; 2018 Jul; 27(7):1295-1303. PubMed ID: 29626847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.
    Lim KH; Dasari AK; Hung I; Gan Z; Kelly JW; Wemmer DE
    Biochemistry; 2016 Apr; 55(13):1941-4. PubMed ID: 26998642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
    Ilie IM; Caflisch A
    Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the β-sheet edge of peptide self-assembly using a model protein.
    Shiga S; Makabe K
    Proteins; 2021 Jul; 89(7):845-852. PubMed ID: 33576533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRET studies of various conformational states adopted by transthyretin.
    Ghadami SA; Bemporad F; Sala BM; Tiana G; Ricagno S; Chiti F
    Cell Mol Life Sci; 2017 Oct; 74(19):3577-3598. PubMed ID: 28478513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.